| Valuation method | Value, £ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 28.10 | 418 |
| Intrinsic value (DCF) | 1.84 | -66 |
| Graham-Dodd Method | n/a | |
| Graham Formula | 0.50 | -91 |
Ascom Holding AG is a Swiss-based leader in healthcare ICT and mobile workflow solutions, serving hospitals, long-term care facilities, and enterprises globally. The company specializes in nurse call and monitoring systems, including its flagship teleCARE IP platform, which integrates nurse call, alerts, messaging, and wander management. Additionally, Ascom offers Digistat and Unite software suites, enhancing clinical workflows and data orchestration. Its hardware portfolio includes mobile devices, DECT/VoWiFi handsets, and pagers, complemented by consulting, implementation, and support services. Operating in the Medical Equipment & Services sector, Ascom differentiates itself through workflow optimization and real-time communication solutions, addressing critical needs in acute and long-term care settings. With a market cap of CHF 117.6 million, the company maintains a strong presence in Europe and beyond, leveraging innovation to improve healthcare efficiency.
Ascom Holding AG presents a niche investment opportunity in the healthcare technology space, with a focus on workflow optimization and communication systems. The company’s revenue of CHF 286.7 million and net income of CHF 3.7 million (FY 2024) reflect stable operations, though its modest EPS (CHF 0.10) and beta of 1.12 suggest moderate volatility. Strengths include zero debt and CHF 18.6 million in cash, providing financial flexibility. However, the competitive healthcare IT landscape and reliance on capital expenditure (CHF -4.4 million) pose risks. The dividend yield (CHF 0.10 per share) may appeal to income-focused investors, but growth depends on adoption of its integrated solutions in an increasingly digital healthcare environment.
Ascom competes in the healthcare ICT segment by combining hardware (e.g., DECT handsets) with software (e.g., Unite workflow orchestration), targeting operational efficiency in care delivery. Its competitive edge lies in specialized nurse call systems (teleCARE IP) and real-time data integration, which are critical for acute care settings. However, the company faces pressure from larger medtech firms with broader portfolios and deeper R&D resources. Ascom’s Swiss base grants it credibility in regulated markets, but its relatively small scale (vs. multinational peers) limits global reach. Differentiation through workflow-centric solutions helps retain hospital clients, but pricing competition from low-cost Asian manufacturers and SaaS-based rivals could erode margins. The lack of debt is a strength, but reinvestment in innovation is essential to maintain relevance against EHR giants expanding into workflow tools.